Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Patel Sanj K
Relationship:  
City:   Lexington
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   63,012    

Indirect Shares

  109,795      
Direct Value   $1,214,241    

Indirect Value

  $2,115,750      
Total Shares   172,807      
Total Value   $3,329,991      


Kiniksa Pharmaceuticals, Ltd.
 $1,214,241 Kiniksa Pharmaceuticals, Ltd.
 $1,214,241
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA President & CEO, Direc... 2015-06-22 0 2015-06-22 0    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA 2024-04-08 63,012 2024-04-08 109,795    Premium*  
* Premium Members only  

Records found :    93         Free Registration Required For Full Results.    Limit: 25

Download
  Page 4 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2022-09-02 4 OE $0.00 $0 D/D 6,569 24,325 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2023-03-16 4 OE $0.00 $0 D/D 6,569 28,965 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2023-03-16 4 D $11.46 $22,106 D/D (1,929) 27,036 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2023-03-20 4 OE $0.00 $0 D/D 12,002 39,038 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2023-03-20 4 D $11.12 $39,176 D/D (3,523) 35,515 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2023-04-10 4 D $10.71 $31,412 D/D (2,933) 42,574 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2023-04-10 4 OE $0.00 $0 D/D 9,992 45,507 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2023-09-01 4 OE $0.00 $0 D/D 9,992 52,566 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2023-09-01 4 D $17.76 $78,712 D/D (4,432) 48,134 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2023-09-02 4 OE $0.00 $0 D/D 6,569 54,703 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2023-09-02 4 D $17.76 $38,841 D/D (2,187) 52,516 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2024-03-04 4 AS $21.31 $273,834 I/I (12,742) 70,594 0 %
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2024-03-06 4 AS $21.00 $117,222 I/I (5,582) 65,012 0 %
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2024-03-07 4 AS $21.02 $1,366,552 I/I (65,012) 0 0 %
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2024-04-01 4 OE $0.00 $0 D/D 6,482 58,998 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2024-04-01 4 D $19.70 $37,489 D/D (1,903) 57,095 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2024-04-08 4 OE $0.00 $0 D/D 9,992 67,087 0 -
KNSA Kiniksa Pharmaceuticals, ... CHAIRMAN & CEO   •       •      –    2024-04-08 4 D $17.90 $72,943 D/D (4,075) 63,012 0 -

  93  Records found
  1   2   3   4     
  Page 4 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed